[Interpretation of the JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease]

Zhongguo Dang Dai Er Ke Za Zhi. 2021 Mar;23(3):213-220. doi: 10.7499/j.issn.1008-8830.2010134.
[Article in Chinese]

Abstract

Kawasaki disease is the main cause of acquired heart disease in children. The cardiovascular sequelae of Kawasaki disease, such as coronary artery lesion and giant coronary aneurysm, have a great impact on children's physical and mental health. The Japanese Circulatory Society and the Japanese Society of Cardiac Surgery jointly released the JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease in July, 2020, which systematically introduces the advances in the diagnosis and management of cardiovascular sequelae of Kawasaki disease. The article gives an interpretation in the severity evaluation of Kawasaki disease and diagnosis, treatment and long-term management of cardiovascular sequelae in the guideline.

川崎病是导致儿童后天性心脏病的主要原因。川崎病并发冠状动脉损害及巨大冠状动脉瘤等心血管后遗症给儿童的身心健康造成很大影响。日本循环学会(JCS)联合日本心脏外科学会(JSCS)2020年7月共同发布了《川崎病心血管后遗症的诊断和管理指南(JCS/JSCS 2020)》,系统介绍了川崎病心血管后遗症的诊疗和管理新进展。该文对该指南中关于川崎病严重程度的评估及心血管后遗症的诊断、治疗、远期管理等进行了解读。

MeSH terms

  • Child
  • Coronary Aneurysm*
  • Coronary Vessels
  • Disease Progression
  • Heart Diseases*
  • Humans
  • Mucocutaneous Lymph Node Syndrome* / complications
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Mucocutaneous Lymph Node Syndrome* / therapy